Sonmez, Mehmet <br/><br/>
Effect of LMO2 protein expression on survival in chronic myeloid leukemia patients treated with imatinib mesylate.  [electronic resource] 

 -  Hematology (Amsterdam, Netherlands)  Aug 2009 
 - 220-3 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1607-8454 
<br/><br/><label>Standard No.: </label>10.1179/102453309X426245  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adaptor Proteins, Signal Transducing<br/>Adolescent<br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Antineoplastic Agents--therapeutic use<br/>Benzamides<br/>DNA-Binding Proteins--biosynthesis<br/>Female<br/>Humans<br/>Imatinib Mesylate<br/>LIM Domain Proteins<br/>Leukemia, Myelogenous, Chronic, BCR-ABL Positive--drug therapy<br/>Male<br/>Metalloproteins--biosynthesis<br/>Middle Aged<br/>Piperazines--therapeutic use<br/>Prognosis<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--antagonists & inhibitors<br/>Proto-Oncogene Proteins--biosynthesis<br/>Pyrimidines--therapeutic use<br/>Survival Rate<br/>Young Adult